Detection of Malignant Tumors with Radiopharmaceutical Tc-99m FAPI and SPECT imaging
Not Applicable
- Conditions
- Malignant neoplasm.Malignant neoplasmC00-C96
- Registration Number
- IRCT20240626062262N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Volunteering to participate in clinical trials and signing an informed consent form (signed by participant, parent, or legal representative) Patients with suspected or new diagnosed or previously treated malignant tumors Inconclusive findings on imaging modalities.
Exclusion Criteria
Pregnant and lactating women The inability or unwillingness of the research participant, parent, or legal representative to provide written informed consent
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method